Disclosure Of Entity's Operating Segments [Text Block]

Marinomed Biotech AG - Filing #1129987

Concept	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	As at 2019-12-31
Disclosure of entity's operating segments [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	—	—	—	8,124 EUR	—	—	—	—	6,145 EUR	—
Depreciation and amortisation expense	—	—	—	4,284,000 EUR	—	—	—	—	3,272,000 EUR	—
Tax expense (income)	—	—	—	35,000 EUR	—	—	—	—	44,000 EUR	—
Profit (loss) before tax	—	—	—	6,007 EUR	—	—	—	—	7,212 EUR	—
Profit (loss)	6,010 EUR	—	- EUR	6,010 EUR	- EUR	- EUR	- EUR	7,216 EUR	7,216 EUR	—
Assets	—	23,502 EUR	—	—	—	—	—	—	—	19,502 EUR
Cash flows from (used in) operating activities	—	—	—	6,885 EUR	—	—	—	—	7,641 EUR	—
Cash flows from (used in) investing activities	—	—	—	3,964 EUR	—	—	—	—	2,376 EUR	—
Cash flows from (used in) financing activities	—	—	—	8,006 EUR	—	—	—	—	20,321 EUR	—
Disclosure of products and services [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]